Antidote AI
PrivateLast Round
Seed
Jan 21, 2026
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Antidote AI is a healthcare technology company that provides a conversational clinical operating system designed to automate clinical workflows, documentation, and decision support for medical providers.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, EHR & EMR, Workflow Automation, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antidote AI Comparables
Compare Antidote AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealOS | 91% | |
| Ambience Healthcare | 81% | |
| Freed | 80% |
Antidote AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 21, 2026 |
Antidote AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lakestar | Seed |
| The LegalTech Fund | Seed |
| Concept Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
$5M round led by Lakestar
Antidote AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antidote AI's valuation, stock price, and market status.
Is Antidote AI a public or private company?
Antidote AI is a private company.
What is the current stock price of Antidote AI?
Antidote AI is a private company with no public stock price. No recent secondary market data is available.
How much is Antidote AI worth (valuation)?
Valuation information for Antidote AI is not publicly available.
Can I buy Antidote AI stock?
Antidote AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Antidote AI's last funding round?
Antidote AI's most recent funding round was Seed on January 21, 2026.
Who are the main investors in Antidote AI?
Key investors in Antidote AI include Lakestar.
Will Antidote AI IPO soon?
No public IPO plans have been announced for Antidote AI.
How can I track Antidote AI secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antidote AI's secondary market activity and sign up for updates.